Category: Studies

Study: Psilocin “Exhibits Significant Therapeutic Potential in the Treatment of Epilepsy”

A study being published in the journal Pharmacology Research & Perspectives found that psilocin, the active metabolite of psilocybin, “exhibits significant therapeutic potential in the treatment of epilepsy.” Researchers from Tehran University of Medical Sciences, Iran University of Medical Sciences, and Tarbiat Modares University conducted experiments using mouse seizure models to evaluate psilocin’s effects. The …

Continue reading

Study: CBD and CBG Show Potential in Combating HER2-Positive Ovarian Cancer

A new study published in the peer-reviewed journal ACS Omega shows that cannabinoids, including cannabidiol (CBD) and cannabigerol (CBG), could serve as promising treatments for HER2-positive ovarian cancer. Researchers from Kasetsart University, Nation University, King Mongkut’s University of Technology, and the Thailand Science Park conducted kinase inhibition assays, surface plasmon resonance (SPR), molecular docking, and …

Continue reading

Study: Combination of CBD and THC May Reduce Migraine Symptoms

A study published in the journal Cephalalgia using an animal model found that a combination of CBD and THC may significantly reduce migraine symptoms. Researchers from the University of Iowa, Leiden University Medical Center in the Netherlands, and the Department of Veterans Affairs Health Center in Iowa explored how these cannabinoids influence light aversion, pain …

Continue reading

Study: Psilocybin and MDMA Show Potential for Treating Prolonged Grief Disorder

Psychedelics, particularly psilocybin and MDMA, may be a useful tool in combatting prolonged grief disorder, according to a new study conducted by researchers from Johns Hopkins University School of Medicine and the University of Virginia. “Prolonged Grief Disorder (PGD) is distinct from yet related to non-pathologic grief, depression, addiction, and Post-Traumatic Stress Disorder (PTSD) with …

Continue reading

Psilocybin Shows Potential in Treating Repetitive Mild Head Injuries, Finds Study

A new study published by bioRxiv and the U.S. National Library of Medicine finds that psilocybin could help mitigate the effects of repetitive mild head injuries, a condition linked to cognitive decline and neurodegenerative diseases. For the study, researchers from Northeastern University, Delaware State University, and Indiana University examined the impact of psilocybin on an …

Continue reading

Study: CBD Induces Apoptosis and Inhibits Growth in Colorectal Cancer Cells, Regardless of Mutation

A new study finds that cannabidiol (CBD) may effectively combat colorectal cancer (CRC), showing antitumor effects across multiple cell lines, regardless of genetic mutations. Published in the journal ACS Pharmacology & Translational Science, researchers from The University of Queensland and the University of Newcastle in Australia tested CBD on four CRC cell lines—HCT116, HT-29, LS174T, …

Continue reading

Study: Psilocybin Therapy May Help Those With Parkinson’s Disease Overcome Anxiety and Pessimism

Psilocybin-assisted psychotherapy could lead to significant improvements in anxiety, pessimism, and disease acceptance among those with Parkinson’s disease, according to researchers from the University of Geneva and Geneva University Hospital. Published in the Journal of Parkinson’s Disease, the study focused on a 43-year-old patient who struggled with anxious ruminations and difficulty adjusting to her diagnosis. …

Continue reading

THCV and CBD Mucoadhesive Strips Linked to Weight Loss and Metabolic Benefits, Study Finds

A new placebo-controlled study found that mucoadhesive strips containing tetrahydrocannabivarin (THCV) and cannabidiol (CBD) led to significant weight loss and metabolic improvements over 90 days. The study involved 44 participants, including 31 women and 13 men, with an average age of 51.75 years. Researchers tested two different doses: 8 mg THCV/10 mg CBD and 16 …

Continue reading

Study: Patients With Cancer Who Use Medical Marijuana Report Significant Improvements in Symptoms, But Affordability an Issue

A recent study published by the U.S. National Library of Medicine found that patients with cancer who use medical marijuana report substantial improvements in managing symptoms. The study found that although most cancer patients find symptom relief from using medical marijuana, high out-of-pocket costs remain a major barrier, particularly for those already facing financial hardship. …

Continue reading

Study: Cannabidiol (CBD) Disrupts Bacterial Cell Walls, Showing Potential as an Antibiotic Alternative

A new study published in the Journal of Proteomics explores the antibacterial properties of cannabidiol (CBD), revealing its potential as an alternative to traditional antibiotics. The research focused on Bacillus licheniformis, Staphylococcus aureus, and Enterococcus faecium, using bacterial inhibition assays, label-free proteomics, and metabolomics to analyze CBD’s effects. The findings indicate that CBD causes significant …

Continue reading